Talking Point Issue 35

Investments to meet your needs This issue of Talking Point highlights some of them – including our solutions for high-protein sports nutrition, a pioneering pilot plant for lactose production, and clinical studies to discover new milk-based ingredients for treating chronic conditions.

Arla Foods Ingredients has embarked on a new year where investments to extend production capacity and meet growing market demands are high on the agenda.
At our whey processing plant in Denmark, construction of a new spray-drying tower is underway to expand production of special nutritional ingredients. The success of our joint venture plant in Argentina has also prompted a decision to increase capacity by 25%.

Intensive efforts are now in progress to find a suitable entry point in North America. Once this is in place, we will be well on target to reach our 2015 strategic target – a doubling of our total production volume from 2010.

Another interesting development for us is the acquisition of the German dairy Allgäuland-Käsereien by our parent company, Arla Foods. Allgäuland-Käsereien holds a 30% stake in the whey joint venture Milei. Following the acquisition, Arla Foods has gained an influence in the company’s future through representation on the Milei board. Here, we look forward to working with Milei’s management and the Japanese majority stakeholder, Morinaga.

Within our organisation, research and innovation continue to be highly visible activities.

Following on from a great 2011, the new year is off to an exciting start. We wish you all the best for 2012.